Abstract

Background: Obstructive sleep apnea (OSA) is prevalent in pregnancy and it is associated with adverse pregnancy-related outcomes such as gestational diabetes, pre-eclampsia, and low birth weight. Maternal systemic inflammation is proposed to be one of the main intermediate mechanisms. However, the effects of OSA on systemic inflammation are unknown in normal pregnancy.Methods: Women in the 3rd trimester underwent hospital polysomnography to evaluate whether OSA increases systemic inflammation in normal pregnancy and its potential association with adverse fetal outcomes. OSA was defined as an apnea–hypopnea index (AHI) of ≥ 5 h−1. Plasma cytokines levels (TNF-α, IL-1β, IL-6, IL-8, and IL-10) were determined by multiple immunoassays.Results: We included 11 patients with OSA and 22 women with AHI < 5 h−1, who were homogeneous in age, and body mass index (BMI). Women with OSA had significant higher levels of TNF-α, IL-1β, IL-8, and IL-10. We found significant correlations between AHI during REM and TNF-α (r = 0.40), IL-1β (r = 0.36), IL-6 (r = 0.52), IL-8 (r = 0.43), between obstructive apnea index and TNF-α (r = 0.46) and between AHI and IL-1β (r = 0.43). We also found that CT90% was related to IL-8 (r = 0.37). There were no significant differences in neonatal characteristics; however, we found inverse correlations between TNF-α and IL-8 with birth weight (both r = −0.48), while IL-8 showed a significant inverse relationship with neonatal gestational age (r = −0.48).Conclusions: OSA in our normal pregnancy population was associated with higher systemic inflammation, which was related to obstructive events, especially during REM sleep. Moreover, systemic inflammation was inversely correlated with neonatal birth weight and age.

Highlights

  • Obstructive sleep apnea (OSA) is a common disorder characterized by the presence of repetitive episodes of total or partial airflow cessation in the upper airway during sleep despite increased respiratory effort [1]

  • Interleukin 10 (IL-10) in OSA and healthy pregnant women who were homogeneous in age, and body mass index (BMI) in the third trimester; [2] to relate systemic inflammation with adverse maternal and fetal outcomes

  • To obtain the sample size pre-determined for the experimental group, and to include 11 pregnant women classified as OSA, we required assessing for eligibility 130 pregnant women, 42 were not selected (25 refused, 1 technical sleep study dropout, 1 twin pregnancy, 4 delivery before PSG, 1 change of address), and we needed to perform PSG to 88 women

Read more

Summary

Introduction

Obstructive sleep apnea (OSA) is a common disorder characterized by the presence of repetitive episodes of total (apneas) or partial (hypopneas) airflow cessation in the upper airway during sleep despite increased respiratory effort [1]. Apneas and hypopneas are frequently accompanied by a decrease in arterial oxygen saturation that normalizes with breathing resumption producing repeated cycles of hypoxiareoxygenation [2], which are associated to an increase in pro-inflammatory cytokines in general population [3, 4]. These cytokines are secreted in different tissues, including adipose tissue in a close relationship between obesity and OSA. Obstructive sleep apnea (OSA) is prevalent in pregnancy and it is associated with adverse pregnancy-related outcomes such as gestational diabetes, pre-eclampsia, and low birth weight. The effects of OSA on systemic inflammation are unknown in normal pregnancy

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call